An Evaluation of the Pharmacokinetics and Pharmacodynamics of Oral Parathyroid Hormone [PTH (1-34)] and NATPARA in Patients With Hypoparathyroidism

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 04 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

23 Sep 2019 According to an Entera Bio media release, full data from this study will be published in a leading medical journal.
23 Sep 2019 According to an Entera Bio media release, Professor Sofia Ish-Shalom, at the Endocrine Research Center at Lin Medical Center, is the principal investigator of this study.
23 Sep 2019 According to an Entera Bio media release, data (n=16) from this study were presented at the merican Society for Bone and Mineral Research (ASBMR) Annual Meeting.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com